Showing 8931-8940 of 20387 results for "".
- Bariatric Surgery Outperforms GLP-1 Drugs in Slowing Kidney Disease Progression in Type 2 Diabeticshttps://reachmd.com/news/bariatric-surgery-outperforms-glp-1-drugs-in-slowing-kidney-disease-progression-in-type-2-diabetics/2468555/A recent study conducted by the Cleveland Clinic has revealed that bariatric surgery offers substantial kidney-protective benefits for patients with type 2 diabetes, obesity, and chronic kidney disease (CKD) compared to treatment with GLP-1 receptor agonist medications. Published in Annals of
- Study Finds Causal Links Between Type 1 Diabetes and Key Autoimmune Skin Diseaseshttps://reachmd.com/news/study-finds-causal-links-between-type-1-diabetes-and-key-autoimmune-skin-diseases/2467454/China: A recent study has unveiled significant associations between type 1 diabetes mellitus (T1DM) and various autoimmune skin diseases, employing Mendelian randomization (MR) to elucidate these links. This research, published in Heliyon Journal, highlights the potential for genet
- Insulin Resistance: Bridging Diabetes Management and Cognitive Healthhttps://reachmd.com/news/insulin-resistance-bridging-diabetes-management-and-cognitive-health/2475484/As insulin resistance remains a significant concern in diabetes management, its role in cognitive health highlights an emerging area for interdisciplinary research and clinical strategy. For clinicians treating type 2 diabetes, convent
- Incretin Therapies in Type 1 Diabetes: Reappraisal and Geriatric Considerationshttps://reachmd.com/news/incretin-therapies-in-type-1-diabetes-reappraisal-and-geriatric-considerations/2485909/A narrative review in Diabetology synthesizes experimental, clinical trial, and real-world evidence on incretin hormones (GLP-1 and GIP) and incre
- Advancing Maternal Care: Automated Insulin Systems in Type 1 Diabeteshttps://reachmd.com/news/advancing-maternal-care-automated-insulin-systems-in-type-1-diabetes/2484481/Automated closed-loop insulin delivery increased time in pregnancy glucose targets by roughly three hours per day in a randomized multicenter trial
- Exercise Interventions: Comparative Effects on Cardiovascular Outcomes in Type 2 Diabeteshttps://reachmd.com/news/exercise-interventions-comparative-effects-on-cardiovascular-outcomes-in-type-2-diabetes/2474481/Recent studies affirm that aerobic training effectively lowers blood pressure and enhances lipid profiles, whereas combined training—integrating both aerobic and resistance exercises—yields superior cardiovascular benefits. These findin
- Bridging the Gap: Integrated Management of MASLD and Type 2 Diabeteshttps://reachmd.com/news/bridging-the-gap-integrated-management-of-masld-and-type-2-diabetes/2471856/Recent findings demonstrate that the metabolic disturbances common to MASLD and T2DM — including insulin resistance, ectopic lipid storage, and systemic inflammation — provide a fundamental premise for integrated treatment. Grasping these shared processes fosters t
- New Molecular Insights into Bariatric Surgery's Impact on Obesity and Type 2 Diabeteshttps://reachmd.com/news/new-molecular-insights-into-bariatric-surgerys-impact-on-obesity-and-type-2-diabetes/2467873/by Susann-C. Ruprecht, Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke
- Metformin and AGIs Show Potential for Improved Outcomes in COVID-19 Patients with Type 2 Diabeteshttps://reachmd.com/news/metformin-and-agis-show-potential-for-improved-outcomes-in-covid-19-patients-with-type-2-diabetes/2467135/A team of researchers led by Dr. Dao Wen Wang at Huazhong University of Science and Technology has conducted a comprehensive retrospective study analyzing the effects of different diabetes medications on COVID-19 outcomes. This study, involving
- New Drug Could Prevent Diabetic Eye and Kidney Disease in People With Diabeteshttps://reachmd.com/news/new-drug-could-prevent-diabetic-eye-and-kidney-disease-in-people-with-diabetes/2457098/New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease. The University of Bristol-led research is published in